Nano-chip in a capsule identifies bacterial infections within minutes
Author: Wiida Fourie-Basson
A microbiologist and an electronic engineer from Stellenbosch University have developed a proof-of-concept nanowire biological sensor that can identify any of the major disease-causing bacteria such as Escherichia coli, Salmonella or Vibrio cholera within ten to fifteen minutes.
In the not too distant future, this combination of nanotechnology and microbiology could make the diagnosis of patients during an epidemic or outbreak an order of magnitude faster, more accurate and more affordable.
Prof Leon Dicks, an internationally acclaimed microbiologist, joined forces with Prof Willie Perold, also an internationally acclaimed scientist in the field of superconductors and nanoelectrical devices. Together they conceptualised the idea of a nanochip that would be able to detect bacteria and viruses in the patient’s stomach within a few minutes after being swallowed.
Mr Deon Neveling, a postgraduate student in the Department of Microbiology at SU, was given the task to put this concept to the test as part of his research for a master’s degree in microbiology.
From the engineering side, Prof Perold and one of his doctoral students, Stanley van den Heever, developed a zinc oxide nanogenerator which generates electricity the moment the nanowires are disturbed. This is the first time that it has been done in South Africa.
Then Prof Perold bumped into Prof Dicks after a research meeting and they shared thoughts: “We came up with the idea to combine the sensor with ‘biological bait’ to selectively attract bacteria. The idea was that the movement would generate an electrical signal which can instantly be picked up,” he says.
In order to prepare the nanogenerator for biological use, the engineers constructed a silicon chip of 1cm by 1cm in size. They then stacked zinc oxide molecules on top of each other to form a nanowire (only visible with an electron microscope). Thousands of these nanowires are positioned in such a way that the slightest disturbance of their structure will lead to, what engineers call, piezoelectric energy. This energy is converted to electrical energy and then amplified to produce a voltage reading.
Enter the microbiologists: The concept was tested by attaching lysozyme molecules (small disease-fighting proteins present in our saliva) to the tip of each nanowire. As soon as antibodies specific to the lysozyme adhered to the nanowires, it caused a shift in the alignment of the zinc oxide molecules. This was observed as a change in electrical output and proof that the concept works.
The reverse of the concept also holds true. That is, by attaching specific antibodies to the nanowires, they will detect the antigens characteristic of a specific pathogen (disease causing microorganism) and report the presence of the pathogen within seconds.
The key to the concept is linking the correct antibody to the nanowires to form a perfect, “one and only”, match with the antigen.
Prof Dicks says the concept can best be explained by comparing it with fishing.
“We use bait (in the form of an antibody) to fish for antigens in the patient’s gastro-intestinal tract. In our case the bait is attached to thousands of zinc oxide nanowires cast on a silicon chip. In real life the chip will be constructed small enough to be encased in a capsule. Ten minutes after swallowing the capsule, the nanochip is released and the fishing trip starts.
“Our dream is to transfer the electrical signal, which is selected to be unique to each pathogen, to a receiver such as a smartphone,” he adds.
This part of the concept still has to be developed. But, says Prof Dicks, the important thing is that the nanochip concept works. “Instead of prescribing a broad-based antibiotic, or waiting 48 hours for the lab tests to come back, a doctor will be able to immediately prescribe the correct antibiotic to target the pathogen, and by doing so, put less stress on the body’s immune system.”
Could this concept work for identifying deadly viruses like Ebola?
“Certainly”, he says, “as long as you have antibodies specific to antigens that are unique to the Ebola virus.”
Antigens are usually proteins located on the surface of cells. These proteins act as a ‘signature’ of that specific cell. This ‘signature’ is then recognised by specific antibodies.
At present it is difficult and time-consuming to diagnose a patient with the Ebola virus. This is because the early signs and symptoms of Ebola resemble that of several other potentially fatal diseases, such as malaria, typhoid fever, shigellosis, cholera, leptospirosis and meningitis.
In the short term, Prof Dicks plans to work with a group of French scientists to develop a nanochip biosensor implant that would report secondary infections: “The idea is to incorporate the biosensor into a patient during, for instance, a hip transplant. This would then allow the surgeons to detect the slightest form of secondary infections that may develop during the recovery phase,” he explains.
The results of the research were recently published in the article “A nanoforce ZnO nanowire-array biosensor for the detection and quantification of immunoglobulins” in the journal Sensors and Actuators B: Chemical. The basics of the biosensor is described in the article “Effect of seed layer deposition, Au film layer thickness and crystal orientation on the synthesis of hydrothermally grown ZnO nanowires”, which was submitted to Current Nanoscience.
Prof Leon Dicks
Tel: 021 808-5849
Prof Willie Perold
Tel: 021 808-4368
The research was also recently covered in a newspaper article in Die Burger
- World experts to discuss biobased economy
- Post-Graduate Programme in Biofuels
- PhD Student Winschau Fayghan van Zyl Wins Best Poster Award @ the 9th Biotechnology Congress of America
- MSc student Steffi Davison tutoring primary school learners at Lynedoch Primary School
- Domestic Rainwater Harvesting Solar Pasteurization Treatment Systems in Enkanini Informal Settlement (Stellenbosch)